TorreyPines Therapeutics Report issue

For profit Phase 1 Phase 2
Founded: La Jolla CA United States (2000)
Status: Acquired by Raptor Pharmaceuticals Corp. (2009) → now Horizon Pharma (2016)

Organization Overview

First Clinical Trial
2006
NCT00567086
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree